Novel GA/βCD/VDC Nanovehicle Enhances Oral Bioavailability of Cholecalciferol
The GA/βCD/VDC nanovehicle significantly enhances the oral bioavailability of cholecalciferol, improving absorption and retention in tissues.
Therapeutic Area
Therapeutic area intelligence for Nutraceuticals with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.